시장보고서
상품코드
1532860

바이러스 증감제 시장 : 제품 유형별, 투여 경로별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Viral Sensitizers Market, By Product Type, By Route of Administration, By Application, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

바이러스 증감제 시장 규모는 2023년 5억 4,854만 달러로 2024년부터 2032년까지 13.5%의 CAGR로 확대될 것으로 예상됩니다.

바이러스 증감제 시장 - 시장 역학

바이러스 감염 증가로 바이러스 증감제 시장 수요 확대 주도

바이러스 감염증의 증가는 바이러스 증감제 시장 확대를 촉진하는 중요한 요인이 되고 있습니다. 바이러스 증감제는 바이러스 감염을 감지하고 대응하는 데 매우 중요하며, 집단 감염과 전염병이 빈번하게 발생함에 따라 그 중요성이 점점 더 커지고 있습니다. 바이러스 감염증이 증가함에 따라 바이러스 증감제의 수요가 크게 증가하고 있습니다. 세계보건기구(WHO)에 따르면, 전 세계 3억 명 이상의 사람들이 간염, HIV 등 만성 바이러스 감염에 시달리고 있어 효과적인 치료법이 시급히 필요한 것으로 나타났습니다. 예를 들어, 미국 질병예방통제센터(CDC)는 지난 1년 동안 독감 및 기타 바이러스 감염이 15% 증가했다고 보고하면서 항바이러스 연구에 대한 관심이 더욱 높아졌다고 밝혔습니다. 이러한 건강에 대한 관심은 제약회사와 R&D 기관들이 새로운 바이러스 증감제 개발에 박차를 가하고 있으며, 항바이러스 약물의 효능을 높이고 환자 치료 결과를 개선하기 위한 혁신적인 솔루션에 많은 자금이 투입되고 있습니다.

바이러스 증감제 시장 - 주요 인사이트

당사의 연구 분석가들의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 13.5%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 바이러스 증감제가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

투여 경로를 세분화하면 2023년 경구제가 주요 유형으로 나타났습니다.

용도별로는 암 분야가 2023년 주요 유형으로 꼽혔습니다.

지역별로는 북미가 2023년 매출 1위

바이러스 증감제 시장 - 세분화 분석:

세계 바이러스 증감제 시장은 제품 유형, 투여 경로, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 바이러스 증감제, 저분자 증감제, 생물학적 증감제 등 세 가지 범주로 나뉩니다. 바이러스 증감제는 항바이러스 요법을 강화하는 데 직접적인 역할을 하기 때문에 이 부문을 주도하고 있습니다. 한편, 단클론항체를 포함한 생물학적 감작제는 높은 치료 특성으로 인해 점점 더 많이 사용되고 있습니다.

시장은 투여 경로에 따라 경구 투여와 정맥 투여의 두 가지 범주로 나뉩니다. 경구 투여는 편의성과 환자 선호도로 인해 주요 투여 경로입니다. 반면, 정맥 투여는 감작제를 신속하고 직접적으로 투여할 수 있다는 점에서 중요하며, 급성 또는 중증 바이러스 감염에 자주 사용됩니다.

바이러스 증감제 시장 - 지리적 인사이트

북미 시장은 선진화된 헬스케어 인프라와 국립보건원(NIH), 대형 제약사 등 연구기관들의 막대한 연구 투자가 시장을 주도하고 있습니다. 특히 미국에서는 바이러스 감작제에 대한 높은 수요를 반영하여 항바이러스 연구에 대한 자금 지원이 증가하고 있습니다. 유럽은 독일, 영국 등 여러 국가들이 새로운 항바이러스 치료제 개발 및 시험에 적극적으로 나서고 있으며, 공중보건 기관과 학술 기관들이 큰 기여를 하고 있습니다. 아시아태평양에서는 의료 수요 증가와 연구 역량 향상에 힘입어 중국, 인도와 같은 국가들이 주요 기업으로 부상하고 있습니다. 반면, 라틴아메리카와 중동은 의료 투자 증가와 공동 연구 노력에 힘입어 더딘 속도지만 점차 시장에서의 입지를 넓혀가고 있습니다.

바이러스 증감제 시장 - 경쟁 상황:

Gilead Sciences, Merck & Co., Roche와 같은 주요 기업들은 광범위한 R&D 역량을 활용하여 새로운 바이러스 증감제를 개발하고 기존 항바이러스 치료제를 강화하는 데 주력하고 있습니다. 예를 들어, 길리어드 사이언스(Gilead Sciences)는 항바이러스제 개발의 최전선에 있으며, 최근 제제 개발 동향은 효능을 향상시키는 것을 목표로 하고 있으며, 머크(Merck & Co.)와 로슈(Roche)도 포트폴리오를 강화하기 위한 연구와 전략적 제휴에 많은 투자를 하고 있습니다. 또한, 신흥 생명공학 기업들도 최첨단 기술과 새로운 화합물을 도입하여 경쟁 환경에 기여하고 있습니다. 학술 기관과 제약사 간의 협업은 혁신을 더욱 촉진하고 있습니다. 이러한 역동적인 환경은 지속적인 개선을 촉진하고 바이러스 감염과 싸우기 위한 첨단 솔루션을 제공할 수 있도록 돕고 있습니다.

목차

제1장 바이러스 증감제 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 바이러스 증감제의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 바이러스 증감제산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 바이러스 증감제 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 바이러스 증감제 시장 상황

  • 바이러스 증감제 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 바이러스 증감제 시장 - 제품 유형별

  • 개요
    • 제품 유형별 부문 점유율 분석
    • 바이러스 증감제
    • 저분자 감작제
    • 생물학적 감작물질

제8장 바이러스 증감제 시장 - 투여 경로별

  • 개요
    • 투여 경로별 부문 점유율 분석
    • 경구
    • 정맥
    • 기타

제9장 바이러스 증감제 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 종양학
    • 감염증
    • 기타

제10장 바이러스 증감제 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 병원과 진료소
    • 학술연구기관
    • 제약·바이오테크놀러지 기업

제11장 바이러스 증감제 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 바이러스 증감제업계

  • 경쟁 대시보드
  • 기업 개요
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca PLC
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • Eli Lilly and Company
    • Genentech, Inc.(a member of the Roche Group)
    • GlaxoSmithKline plc
    • Incyte Corporation
    • Johnson & Johnson
    • Merck &Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Others

제13장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Viral Sensitizers Market size was valued at USD 548.54 Million in 2023, expanding at a CAGR of 13.5% from 2024 to 2032.

The Viral Sensitizers Market involves compounds that enhance the efficacy of antiviral therapies by making cells more susceptible to viral infections. Growing incidences of viral infections and the need for effective antiviral treatments are pushing market expansion, with the World Health Organization reporting over 300 million cases of chronic viral infections globally in 2023. However, high research and development costs and regulatory hurdles present significant challenges. Opportunities are emerging through advancements in drug delivery systems and increasing investments in antiviral drug research, with notable progress in novel viral sensitizers showing promise in preclinical trials.

Viral Sensitizers Market- Market Dynamics

Growing Incidences of Viral Infections Drive Demand for Viral Sensitizers Market Expansion

The growing incidences of viral infections are indeed a significant factor driving the expansion of the viral sensitizers market. Viral sensitizers are crucial in detecting and responding to viral infections, which is increasingly important as outbreaks and pandemics become more frequent. Growing incidences of viral infections are significantly driving the demand for viral sensitizers. According to the World Health Organization, over 300 million people worldwide are affected by chronic viral infections, such as hepatitis and HIV, highlighting the urgent need for effective treatments. For example, the U.S. Centers for Disease Control and Prevention (CDC) reported a 15% increase in cases of influenza and other viral infections in the past year, further fueling interest in antiviral research. This escalating health concern is prompting pharmaceutical companies and research institutions to develop novel viral sensitizers, with significant funding directed toward innovative solutions aimed at enhancing antiviral drug efficacy and improving patient outcomes.

Viral Sensitizers Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.5% over the forecast period (2024-2032)

Based on product type segmentation, Viral Sensitizers was predicted to show maximum market share in the year 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

Based on Application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Viral Sensitizers Market- Segmentation Analysis:

The Global Viral Sensitizers Market is segmented on the basis of Product Type, Route of Administration, Application, End-Users, and Region.

The market is divided into three categories based on product type: Viral Sensitizers, Small Molecule Sensitizers, and Biologic Sensitizers. Viral Sensitizers lead the segment due to their direct role in enhancing antiviral therapies. Small Molecule Sensitizers follow, offering targeted action, while Biologic Sensitizers, including monoclonal antibodies, are increasingly used for their advanced therapeutic properties.

The market is divided into two categories based on the Route of Administration: Oral and Intravenous. Oral administration is the leading route due to its convenience and patient preference, while Intravenous administration is significant for its rapid and direct delivery of sensitizers, often used in acute or severe viral infections.

Viral Sensitizers Market- Geographical Insights

North America leads the market, driven by advanced healthcare infrastructure and substantial research investments from institutions like the National Institutes of Health (NIH) and major pharmaceutical companies. The United States, in particular, has seen increased funding for antiviral research, reflecting a high demand for viral sensitizers. Europe follows, with significant contributions from countries such as Germany and the UK, where public health agencies and academic institutions are actively involved in developing and testing new antiviral treatments. In the Asia-Pacific region, countries like China and India are emerging as key players, propelled by rising healthcare needs and growing research capabilities. Meanwhile, Latin America and the Middle East are gradually expanding their market presence, supported by increasing healthcare investments and collaborative research efforts, albeit at a slower pace.

Viral Sensitizers Market- Competitive Landscape:

Key companies such as Gilead Sciences, Merck & Co., and Roche are prominent, leveraging their extensive R&D capabilities to develop novel viral sensitizers and enhance existing antiviral treatments. Gilead Sciences, for example, has been at the forefront of antiviral drug development, with recent advancements in drug formulations aimed at improving efficacy. Merck & Co. and Roche are also investing heavily in research and strategic partnerships to advance their portfolios. Additionally, emerging biotech firms are contributing to the competitive landscape by introducing cutting-edge technologies and novel compounds. Collaborations between academic institutions and pharmaceutical companies are further driving innovation. This dynamic environment fosters continuous improvement and ensures the availability of advanced solutions for combating viral infections.

Recent Developments:

In June 2024, Virica Biotech Inc. received a $1.5 million investment to enhance the production of its innovative viral sensitizers, which improve the efficacy of viral therapies for cancer treatment. This funding supports advanced manufacturing at their expanded facility in Ottawa.

In January 2024, Virica Biotech Inc. announced a research and development partnership with Oxford Biomedica to enhance the manufacturing processes of lentiviral vector gene therapies. This collaboration aims to leverage viral sensitizers to improve the efficiency and effectiveness of these therapies

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL SENSITIZERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc.

Amgen Inc.

AstraZeneca PLC

Biogen Inc.

Bristol-Myers Squibb Company

Celgene Corporation

Eli Lilly and Company

Genentech, Inc. (a member of the Roche Group)

GlaxoSmithKline plc

Incyte Corporation

Johnson & Johnson

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

Roche Holding AG

Sanofi S.A.

Others

GLOBAL VIRAL SENSITIZERS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Viral Sensitizers
  • Small Molecule Sensitizers
  • Biologic Sensitizers

GLOBAL VIRAL SENSITIZERS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Intravenous
  • Others

GLOBAL VIRAL SENSITIZERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Infectious Diseases
  • Others

GLOBAL VIRAL SENSITIZERS MARKET, BY END-USERS- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies

GLOBAL VIRAL SENSITIZERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Viral Sensitizers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Viral Sensitizers Market Snippet by Product Type
    • 2.1.2. Viral Sensitizers Market Snippet by Route of Administration
    • 2.1.3. Viral Sensitizers Market Snippet by Application
    • 2.1.4. Viral Sensitizers Market Snippet by End-Users
    • 2.1.5. Viral Sensitizers Market Snippet by Country
    • 2.1.6. Viral Sensitizers Market Snippet by Region
  • 2.2. Competitive Insights

3. Viral Sensitizers Key Market Trends

  • 3.1. Viral Sensitizers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Viral Sensitizers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Viral Sensitizers Market Opportunities
  • 3.4. Viral Sensitizers Market Future Trends

4. Viral Sensitizers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Viral Sensitizers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Viral Sensitizers Market Landscape

  • 6.1. Viral Sensitizers Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Viral Sensitizers Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Viral Sensitizers
    • 7.1.3. Small Molecule Sensitizers
    • 7.1.4. Biologic Sensitizers

8. Viral Sensitizers Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Intravenous
    • 8.1.4. Others

9. Viral Sensitizers Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Infectious Diseases
    • 9.1.4. Others

10. Viral Sensitizers Market - By End-Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Users, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Clinics
    • 10.1.3. Academic and Research Institutes
    • 10.1.4. Pharmaceutical and Biotechnology Companies

11. Viral Sensitizers Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Viral Sensitizers Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Viral Sensitizers Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Viral Sensitizers Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Viral Sensitizers Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Viral Sensitizers Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Viral Sensitizers Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc.
    • 12.2.2. Amgen Inc.
    • 12.2.3. AstraZeneca PLC
    • 12.2.4. Biogen Inc.
    • 12.2.5. Bristol-Myers Squibb Company
    • 12.2.6. Celgene Corporation
    • 12.2.7. Eli Lilly and Company
    • 12.2.8. Genentech, Inc. (a member of the Roche Group)
    • 12.2.9. GlaxoSmithKline plc
    • 12.2.10. Incyte Corporation
    • 12.2.11. Johnson & Johnson
    • 12.2.12. Merck & Co., Inc.
    • 12.2.13. Novartis AG
    • 12.2.14. Pfizer Inc.
    • 12.2.15. Roche Holding AG
    • 12.2.16. Sanofi S.A.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제